Life Sciences Pennsylvania launched a series called “[email protected]” for attendees to network in a casual and relaxed atmosphere. Please join us for the opportunity to reconnect with life sciences colleagues from the region as well as to meet newcomers to the community.
*Although the event is complimentary you must register to attend.
When: Thursday, October 17, 2019
Where: 100 Delta Drive, Pittsburgh PA 15238
Time: 5:00 PM - 7:00 PM
- 5:00 - 5:45 PM Registration + Networking
- 5:45 - 5:48 PM Welcome from Christopher Molineaux, President & CEO, Life Sciences Pennsylvania
- 5:48 - 5:52 PM Welcome from Ron Jankowski, VP Scientific Affairs, Cook MyoSite
- 5:52 - 6:00 PM Brief remarks from Dr. Michael B. Chancellor, Director of the Neurology Program in the Department of Urology at the William Beaumont Hospital
- 6:00 - 7:00 PM Networking
Click here to learn more about Cook MyoSite!
Cook MyoSite Incorporated was formed in 2002 as a wholly owned subsidiary of the Cook Group. Cook MyoSite was established to guide the organization into the expanding world of cellular technologies. Cook MyoSite aims to develop and commercialize technology related to the collection, selection, and expansion of human skeletal muscle cells. Through pioneering efforts, research involving the use of adult skeletal muscle-derived cells for tissue augmentation is being investigated as a potential treatment option for patients with a variety of muscle-related disorders.
In addition to clinical research, Cook MyoSite has been developing and commercializing high-quality primary muscle cells and associated reagents to assist researchers performing muscle-related research since 2008. Our brand is committed to providing the research community with products to research and develop cellular treatments for a variety of muscle-related disorders.
Michael B. Chancellor, MD
Director of Neurourology Program in the Department of Urology at the William Beaumont Hospital in Royal Oak, Michigan. Dr. Michael Chancellor, board certified by the American Board of Urology, received his medical degree from Medical College of Wisconsin in Milwaukee.
A prolific author and researcher, Dr. Chancellor has gained national and international recognition in the areas of stem cell and tissue engineering, and drug discovery. He is the inventor of technologies that founded Cook MyoSite, Inc., that is now in multicenter North American trial using adult autologous muscle derived stem cells to treat stress urinary incontinence. He has been recognized as Innovator of the Year by the Pittsburgh Magazine and one of the "Best Doctors in America.
Dr. Chancellor has received funding from the National Institutes of Health for over a decade and he has trained many of today's experts in urology.